相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。Nonmyeloablative allogeneic hematopoietic cell transplantation in relapsed, refractory, and transformed indolent non-Hodgkin's lymphoma
Andrew R. Rezvani et al.
JOURNAL OF CLINICAL ONCOLOGY (2008)
Allogeneic transplantation in lymphoma: current status
Norbert Schmitz et al.
HAEMATOLOGICA (2007)
Umbilical cord blood transplantation after nonmyeloablative conditioning: impact on transplantation outcomes in 110 adults with hematologic disease
Claudio G. Brunstein et al.
BLOOD (2007)
Increased risk of pregnancy complications in patients with essential thrombocythemia carrying the JAK2 (617V>F) mutation
Francesco Passamonti et al.
BLOOD (2007)
Pretransplant positive positron emission tomography/gallium scans predict poor outcome in patients with recurrent/refractory Hodgkin lymphoma
Elias Jabbour et al.
CANCER (2007)
Long-term outcomes after reduced-intensity conditioning allogeneic stem cell transplantation for low-grade lymphoma:: a survey by the French Society of Bone Marrow Graft Transplantation and Cellular Therapy (SFGM-TC)
Stephane Vigouroux et al.
HAEMATOLOGICA-THE HEMATOLOGY JOURNAL (2007)
High-dose chemotherapy using BEAM without autologous rescue followed by reduced-intensity conditioning allogeneic stem-cell transplantation for refractory or relapsing lymphomas: a comparison of delayed versus immediate transplantation
A. S. Buser et al.
BONE MARROW TRANSPLANTATION (2007)
Double unrelated reduced-intensity umbilical cord blood transplantation in adults
Karen K. Ballen et al.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2007)
Indications for allogeneic stem cell transplantation in chronic lymphocytic leukemia: the EBMT transplant consensus
P. Dreger et al.
LEUKEMIA (2007)
Hematopoietic cell transplantation for chronic lymphocytic leukemia: An evolving concept
Mohamed A. Kharfan-Dabaja et al.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2007)
Unrelated versus related allogeneic stem cell transplantation after reduced intensity conditioning
Mehmet Uzunel et al.
TRANSPLANTATION (2006)
Predictors of improved progression-free survival after nonmyeloablative allogeneic stem cell transplantation for advanced chronic lymphocytic leukemia
Jennifer R. Brown et al.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2006)
Clinical outcome following autologous and allogeneic blood and marrow transplantation for relapsed diffuse large-cell non-Hodgkin's lymphoma
Ivan Aksentijevich et al.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2006)
Comparable results of umbilical cord blood and HLA-matched sibling donor hematopoietic stem cell transplantation after reduced-intensity preparative regimen for advanced Hodgkin lymphoma
NS Majhail et al.
BLOOD (2006)
Results of alemtuzumab-based reduced-intensity allogeneic transplantation for chronic lymphocytic leukemia: a British Society of Blood and Marrow Transplantation Study
J Delgado et al.
BLOOD (2006)
Reduced intensity conditioning for allogeneic stem cell transplantation in relapsed and refractory Hodgkin lymphoma: Where do we stand?
Paolo Anderlini et al.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2006)
Allogeneic transplant with reduced intensity conditioning regimens may overcome the poor prognosis of B-cell chronic lymphocytic leukemia with unmutated immunoglobulin variable heavy-chain gene and chromosomal abnormalities (11q- and 17p-)
D Caballero et al.
CLINICAL CANCER RESEARCH (2005)
Hematopoietic cell transplantation after nonmyeloablative conditioning for advanced chronic lymphocytic leukemia
ML Sorror et al.
JOURNAL OF CLINICAL ONCOLOGY (2005)
Reduced-intensity unrelated cord blood transplantation for patients with advanced malignant lymphoma
K Yuji et al.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2005)
Transplantation of 2 partially HLA-matched umbilical cord blood units to enhance engraftment in adults with hematologic malignancy
JN Barker et al.
BLOOD (2005)
Factors associated with outcomes of unrelated cord blood transplant: Guidelines for donor choice
E Gluckman et al.
EXPERIMENTAL HEMATOLOGY (2004)
Graft-versus-lymphoma effect in refractory cutaneous T-cell lymphoma after reduced-intensity HLA-matched sibling allogeneic stem cell transplantation
KE Herbert et al.
BONE MARROW TRANSPLANTATION (2004)
Outcomes after alemtuzumab-containing reduced-intensity allogeneic transplantation regimen for relapsed and refractory non-Hodgkin lymphoma
E Morris et al.
BLOOD (2004)
Allogeneic hematopoietic cell transplantation after fludarabine and 2 Gy total body irradiation for relapsed and refractory mantle cell lymphoma
MB Maris et al.
BLOOD (2004)
Outcomes after transplantation of cord blood or bone marrow from unrelated donors in adults with leukemia
MJ Laughlin et al.
NEW ENGLAND JOURNAL OF MEDICINE (2004)
Transplants of umbilical-cord blood or bone marrow from unrelated donors in adults with acute leukemia
V Rocha et al.
NEW ENGLAND JOURNAL OF MEDICINE (2004)
Nonmyeloablative allogeneic hematopoietic transplantation:: A promising salvage therapy for patients with non-Hodgkin's lymphoma whose disease has failed a prior autologous transplantation
MP Escalón et al.
JOURNAL OF CLINICAL ONCOLOGY (2004)
Comparison of autologous and allogeneic hematopoietic stem cell transplantation for follicular lymphoma
K van Besien et al.
BLOOD (2003)
An EBMT registry matched study of allogeneic stem cell transplants for lymphoma: allogeneic transplantation is associated with a lower relapse rate but a higher procedure-related mortality rate than autologous transplantation
AJ Peniket et al.
BONE MARROW TRANSPLANTATION (2003)
Nonablative allogeneic stem-cell transplantation for advanced/recurrent mantle-cell lymphoma
IF Khouri et al.
JOURNAL OF CLINICAL ONCOLOGY (2003)
Chemoresistant or aggressive lymphoma predicts for a poor outcome following reduced-intensity allogeneic progenitor cell transplantation: an analysis from the Lymphoma Working Party of the European Group for Blood and Bone Marrow Transplantation
SP Robinson et al.
BLOOD (2002)
Role of nonmyeloablative allogeneic stem-cell transplantation after failure of autologous transplantation in patients with lymphoproliferative malignancies
K Branson et al.
JOURNAL OF CLINICAL ONCOLOGY (2002)
Successful treatment of relapsed blastic natural killer cell lymphoma with unrelated cord blood transplantation
T Yoshimasu et al.
BONE MARROW TRANSPLANTATION (2002)
Successful unrelated cord blood transplantation for relapse after autologous transplantation in non-Hodgkin's lymphoma
J Ooi et al.
LEUKEMIA & LYMPHOMA (2002)
Nonablative allogeneic hematopoietic transplantation as adoptive immunotherapy for indolent lymphoma: low incidence of toxicity, acute graft-versus-host disease, and treatment-related mortality
IF Khouri et al.
BLOOD (2001)